Mani Inc
TSE:7730
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 716
2 365.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Mani Inc
Mani Inc
Cost of Revenue
Mani Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mani Inc
TSE:7730
|
Cost of Revenue
-¥10.6B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Hoya Corp
TSE:7741
|
Cost of Revenue
-¥112.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
H
|
Hogy Medical Co Ltd
TSE:3593
|
Cost of Revenue
-¥33B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Shofu Inc
TSE:7979
|
Cost of Revenue
-¥14.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
|
Menicon Co Ltd
TSE:7780
|
Cost of Revenue
-¥55.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Nipro Corp
TSE:8086
|
Cost of Revenue
-¥424.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
Mani Inc
Glance View
Mani, Inc. engages in the development, manufacture, and sale of medical instruments specializing in surgical and dental products. The company is headquartered in Utsunomiya-Shi, Tochigi-Ken and currently employs 3,313 full-time employees. The company went IPO on 2001-06-29. The firm operates through three business segments. The Surgical-related Product segment is engaged in the provision of surgical suture needles and threads, as well as ophthalmic knives, born saws, blood vessel knives and other surgical equipment. The Eyeless Needle-related Product segment is engaged in the provision of eyeless surgical suture needles. The Dental-related Product segment is engaged in the manufacture and sale of dental root canal treatment equipment, such as reamers, files, broaches and cleansers; grinding and abrasive agents, such as carborundum points and silicone points; rotating dental treatment equipment, such as diamond burs, carbide burs, stainless burs and others, as well as dental materials, dental stereomicroscopes, among others.
See Also
What is Mani Inc's Cost of Revenue?
Cost of Revenue
-10.6B
JPY
Based on the financial report for Aug 31, 2024, Mani Inc's Cost of Revenue amounts to -10.6B JPY.
What is Mani Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-10%
Over the last year, the Cost of Revenue growth was -17%. The average annual Cost of Revenue growth rates for Mani Inc have been -20% over the past three years , -10% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
